Drug Safety

The therapy is now approved for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

The FDA has approved the biosimilar pegfilgrastim for treatment to decrease the incidence of infection exhibited from febrile neutropenia.

The FDA has expanded the approval of aprepitant to include in its label the use of a single dose regimen in patients receiving moderately epigenetic chemotherapy.

Opioids are the go-to treatment for cancer-related pain. But is this mainstay poised to change as the opioid crisis continues to grow?

Here are the top 5 Oncology Nursing News stories for March 2019.

The FDA has issued a letter about a possible risk of increased mortality among patients with a type of arterial disease who have paclitaxel-coated implants.

A foundational volume in oncology nursing gets an upgrade.

Preventing central line–associated bloodstream infections is a top priority for healthcare practitioners, and following basic safety protocols, such as handwashing and line flushing, is essential to the effort.

Nurses may not be aware of the reproductive risks of exposure to hazardous drugs, but the new USP Chapter requires a formal notification process.

The chances are high that hazardous drug residue exists wherever the drugs are present. What can nurses do to reduce their risks?

Nurses may think that if they are careful, their routine drug administration activities will not result in hazardous drug leaking and exposure, but even small leaks are problematic.

Despite the warnings, adherence to safe handling precautions by healthcare practitioners is uneven; understanding the risks are essential.

Recent recent update to ASCO/ONS standards for chemotherapy administration safety include considerations for a safe healthcare environment, treatment planning, patient education, and consent.

In working with patients who have cancer, oncology nurses are administering hazardous drugs every day. While some take precaution by using Personal Protective Equipment (PPE), others take a much riskier approach that could be harmful to not only themselves, but also to the people around them.

Despite its safeguarding purpose, a new study has found that nearly half of healthcare personnel contaminated themselves while removing personal protective equipment (PPE).

In her role as division head of Occupational & Environmental Medicine at the University of Maryland, Melissa A. McDiarmid, MD, MPH, spends a lot of her time working with individuals who have been occupationally or environmentally exposed to toxic substances..

As the new USP Chapter 800 regulations for the handling of hazardous drugs are being finalized, stakeholders-including oncology nurses-are preparing for a renewed emphasis on the safe preparation and administration of chemotherapy in their daily practice.

Big changes are ahead for oncology nurses and other healthcare professionals who prepare and administer hazardous drugs, as new regulations for safe handling are being finalized by the US Pharmacopeial Convention (USP).

In September of this year, the National Institute of Occupational Safety and Health (NIOSH) announced a $2.3 million research grant involving 11 of the nation's leading cancer centers.

Several of the nation's leading oncology nurse advocates for raising awareness of the importance of safe handling of chemotherapy drugs gathered recently to discuss some of the current challenges they face in their practices, along with risk reduction strategies that, if adopted, would benefit nurses nationwide.

Underscoring the need to raise awareness among oncology nurses of the importance of adhering to safety precautions when administering chemotherapy and other hazardous drugs, the NIOSH has awarded a $2.3 million research grant to identify exposure risks and promote strategies to combat them.

April is National Safe Handling Awareness Month, a great time to spotlight the ongoing importance of implementing safe practices when handling chemotherapy and other hazardous drugs in the oncology setting-not only for healthcare practitioners, but for patients and their caregivers, too.

Occupational exposure to hazardous drugs is a known risk of working in settings in which these drugs are administered.